These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 11366859)
21. Protease inhibitors and body shape changes. TreatmentUpdate; 1998 Apr; 10(2):4-5. PubMed ID: 11365437 [TBL] [Abstract][Full Text] [Related]
22. The fat redistribution syndrome in patients infected with HIV: measurements of body shape abnormalities. Gerrior J; Kantaros J; Coakley E; Albrecht M; Wanke C J Am Diet Assoc; 2001 Oct; 101(10):1175-80. PubMed ID: 11678488 [TBL] [Abstract][Full Text] [Related]
23. Metabolic problems and PIs. Treat Rev; 1997 Nov; (No 26-27):13. PubMed ID: 11364932 [TBL] [Abstract][Full Text] [Related]
24. Cohort studies: what do they tell us? Chêne G J HIV Ther; 2001 May; 6(2):28-31. PubMed ID: 11501200 [No Abstract] [Full Text] [Related]
25. Clinical significance of treatment-induced lipid abnormalities and lipodystrophy. Smith D J HIV Ther; 2001 May; 6(2):25-7. PubMed ID: 11501199 [No Abstract] [Full Text] [Related]
26. Clinical trials (studies) currently open addressing BHC, wasting and metabolic abnormalities. WORLD; 1999 Nov; (No 103):6. PubMed ID: 11366860 [TBL] [Abstract][Full Text] [Related]
27. Effects of sex and race on lipodystrophy pathogenesis. Nolan D; Mallal S J HIV Ther; 2001 May; 6(2):32-6. PubMed ID: 11501201 [No Abstract] [Full Text] [Related]
28. Lipodystrophy and women: a beach ball on sticks. Marcotte B Posit Aware; 2004; 15(3):14-6. PubMed ID: 15206387 [No Abstract] [Full Text] [Related]
29. Drug reactions & lipodystrophy workshop. Coppedge B STEP Perspect; 1999; 99(3):17-8. PubMed ID: 11366865 [TBL] [Abstract][Full Text] [Related]
30. Side effects. Protease inhibitors and loss of fat. TreatmentUpdate; 2000 Aug; 12(5):1-2. PubMed ID: 12125604 [No Abstract] [Full Text] [Related]
31. [Metabolic side effects of antiretroviral therapy]. van der Valk M; Reiss P Ned Tijdschr Geneeskd; 2008 May; 152(22):1260-4. PubMed ID: 18590059 [TBL] [Abstract][Full Text] [Related]
32. Update on lipodystrophy. Gaucher M Posit Dir News; 1999; 11(1):20-2. PubMed ID: 11366100 [TBL] [Abstract][Full Text] [Related]
33. Adverse drug reactions to protease inhibitors. Manchanda T; Schiedel D; Fischer D; Dekaban GA; Rieder MJ Can J Clin Pharmacol; 2002; 9(3):137-46. PubMed ID: 12422251 [TBL] [Abstract][Full Text] [Related]
34. Sex differences in adverse reactions to antiretroviral drugs. Ofotokun I; Pomeroy C Top HIV Med; 2003; 11(2):55-9. PubMed ID: 12717043 [TBL] [Abstract][Full Text] [Related]
35. Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents. Fantoni M; Del Borgo C; Autore C; Barbaro G Ital Heart J; 2002 May; 3(5):294-9. PubMed ID: 12066561 [TBL] [Abstract][Full Text] [Related]
36. Crossing the waters to the post-HAART era (or Jeanette meets Amalia). Mascolini M J Int Assoc Physicians AIDS Care; 1999 Dec; 5(12):12-23, 28-33, 37-43, 47-51. PubMed ID: 11367348 [TBL] [Abstract][Full Text] [Related]
37. The new body of AIDS: Crixivan bellies, legs, and humps. McCabe L Newsline People AIDS Coalit N Y; 1998 Sep; ():37-9. PubMed ID: 11367490 [TBL] [Abstract][Full Text] [Related]
38. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study. Young J; Rickenbach M; Weber R; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC Antivir Ther; 2005; 10(1):73-81. PubMed ID: 15751765 [TBL] [Abstract][Full Text] [Related]
39. Anti-HIV agents. Leading to lipodystrophy. TreatmentUpdate; 2007 Feb; 19(2):3-4. PubMed ID: 17447312 [No Abstract] [Full Text] [Related]
40. Simplification of antiretroviral treatment--how to sustain success, reduce toxicity and ensure adherence avoiding PI use. Barreiro P; García-Benayas T; Soriano V; Gallant J AIDS Rev; 2002; 4(4):233-41. PubMed ID: 12555697 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]